Subthreshold depression in patients with Parkinson's disease and dementia - Clinical and demographic correlates

International Journal of Geriatric Psychiatry

Volumn 22, Issue 10, 2007, Pages 980-985

  Ehrt, Uwe ^a   Brønnick, Kolbjørn ^a   De Deyn, Peter Paul ^b   Emre, Murat ^c   Tekin, Sibel ^d   Lane, Roger ^d   Aarsland, Dag ^a,e  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c ISTANBUL UNIVERSITY   (Turkey)

^d NOVARTIS PHARMA AG   (Switzerland)

^e UNIVERSITY OF BERGEN   (Norway)

Author keywords

Dementia; Depression; Minor depression; Parkinson's disease; Subthreshold depression

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; MOOD STABILIZER; NEUROLEPTIC AGENT; PLACEBO; RIVASTIGMINE;

ADULT; AGE; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DAILY LIFE ACTIVITY; DEMENTIA; DEMOGRAPHY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEMISPHERIC DOMINANCE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MOTOR DYSFUNCTION; MULTICENTER STUDY; ONSET AGE; PARKINSON DISEASE; PARKINSONISM; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE;

AGE FACTORS; AGE OF ONSET; AGED; AGED, 80 AND OVER; CHOLINESTERASE INHIBITORS; DEMENTIA; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PHENYLCARBAMATES; PSYCHOMOTOR DISORDERS; SEX FACTORS;

EID: 35448933251     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.1774     Document Type: Article

References (40)

1. Aarsland D, Larsen JR Lim NG, et al. 1999. Range of neuropsychiatric disturbances in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 67: 492-496.
2. Aarsland D, Zaccai J, Brayne C. 2005. A systematic review of prevalence studies of dementia in Parkinson's disease. Mov Disord 20: 1255-1263.
3. American Psychiatric Association 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. APA: Washington, DC.
4. Brown RG, MacCarthy B, Gotham AM, et al. 1988. Depression and disability in Parkinson's disease: a follow-up of 132 cases. Psychol Med 18: 49-55.
5. Cole SA, Woodard JL, Juncos JL, et al. 1996. Depression and disability in Parkiason's disease. J Neuropsychiatry Clin Neurosci 8: 20-25.
6. Cummings JL. 1992. Depression and Parkinson's disease: a review. Am J Psychiatry 149: 443-454.
7. Cummings JL, Mega M, Gray K, et al. 1994. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44: 2308-2314.
8. Daniel SE, Lees AJ. 1993. Parkinson's Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl 39: 165-172.
9. Emre M, Aarsland D, Albanese A, et al. 2004. Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med 351: 2509-2518.
10. Fahn S, Elton R, Committee MotUD. 1987. Unified Parkinson's disease rating scale. In Recent Developments in Parkinson's Disease, Fahn S, Marsden C, Calne D, et al. (eds). Macmillan Health Care Information: Florham Park; 153-163.
11. Fleminger S. 1991. Left-sided Parkinson's disease is associated with greater anxiety and depression. Psychol Med 21: 629-638.
12. Fogel J, Eaton WW, Ford DE. 2006. Minor depression as a predictor of the first onset of major depressive disorder over a 15-year follow-up. Acta Psychiatr Scand 113: 36-43.
13. Folstein MF, Folstein SE, McHugh PR. 1975. 'Mini-Mental State'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198.
14. Galasko D, Bennett D, Sano M, et al. 1997. An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord 11(Suppl 2): S33-39.
15. Heun R, Hein S. 2005. Risk factors of major depression in the elderly. Eur Psychiatry 20: 199-204.
16. Hoehn MM, Yahr MD. 1967. Parkinsonism: onset, progression and mortality. Neurology 17: 427-442.
17. Holthoff VA, Beuthien-Banmann B, Kalbe E, et al. 2005. Regional cerebral metabolism in early Alzheimer's disease with clinically significant apathy or depression. Biol Psychiatry 57: 412-421.
18. Karlsen KH, Larsen JP, Tandberg E, Maeland JG. 1999. Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 66: 431-435.
19. Leentjens AF. 2004. Depression in Parkinson's disease: conceptual issues and clinical challenges. J Geriatr Psychiatry Neurol 17: 120-126.
20. Leentjens AF, Lousberg R, Verhey FR. 2002. Markers for depression in Parkinson's disease. Acta Psychiatr Scand 106: 196-201.
21. Liu CY, Wang SJ, Fuh JL, et al. 1997. The correlation of depression with functional activity in Parkinson's disease. J Neurol 244: 493-498.
22. Mayeux R, Stern Y, Rosen J, Leventhal J. 1981. Depression, intellectual impairment, and Parkinson disease. Neurology 31: 045-650.
23. Nilsson FM, Kessing LV, Sorensen TM, et al. 2002. Major depressive disorder in Parkinson's disease: a register-based study. Acta Psychiatr Scand 106: 202-211.
24. Norman S, Troster AI, Fields JA, Brooks R. 2002. Effects of depression and Parkinson's disease on cognitive functioning. J Neuropsychlatry Clin Neurosci 14: 31-36.
25. Papapetropoalos S, Ellul J, Argyriou A, Chroni E, Lekka N. 2006. The effect of depression on motor function and disease severity of Parkinson's disease. Clin Neurology and Neurosurgery 108: 465-469.
26. Rojo A, Aguilar M, Garolera MT, et al. 2003. Depression in Parkinson's disease: clinical correlates end outcome. Parkinsonism Relat Disord 10: 23-28.
27. Schiess MC, Zheng H, Soukup VM, et al. 2000. Parkinson's disease subtypes: clinical classification end ventricular cerebrospinal fluid analysis. Parkinsonism Relat Disord 6: 69-76.
28. Starkstein SE, Berthier ML, Bolduc PL, et al. 1989a. Depression in patients with early versus late onset of Parkinson's disease. Neurology 39: 1441-1445.
29. Starkstein SE, Bolduc PL, Mayberg HS, et al. 1990a. Cognitive impairments and depression in Parkinson's disease: a follow up study. J Neurol Neurosurg Psychiatry 53: 597-602.
30. Starkstein SE, Bolduc PL, Preziosi TJ, Robinson RG. 1989b. Cognitive impairments in different stages of Parkinson's disease. J Neuropsychiatry Clin Neurosci 1: 243-248.
31. Starkstein SE, Mayberg HS, Leiguarda R, et al. 1992. A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 55: 377-382.
32. Starkstein SE, Petracca G, Chemerinski E, et al. 1998. Depression in classic versus akinetic-rigid Parkinson's disease. Mov Disord 13: 29-33.
33. Starkstein SE, Preziosi TJ, Bolduc PL, Robinson RG. 1990b. Depression in Parkinson's disease. J Nerv Ment Dis 178: 27-31.
34. Stek ML, Beckman AT, Verwey B. 1997. Electroconvulsive therapy in late life depression: a review. Tijdschr Gerontol Geriatr 28: 106-112.
35. Tandberg E, Larsen JP, Aarslend D, Cummings JL. 1996. The occurrence of depression in Parkinson's disease. A community-based study. Arch Neurol 53: 175-179.
36. Tandberg E, Larsen JP, Aarsland D, et al. 1997. Risk factors for depression in Parkinson disease. Arch Neurol 54: 625-630.
37. Troster AI, Fields JA, Wilkinson S, et al. 2003. Effect of motor improvement on quality of life following subthalamic stimulation is mediated by changes in depressive symptomatology. Stereotact Funct Neurosurg 80: 43-47.
38. Troster AI, Paolo AM, Lyons KE, et al. 1995a. The influence of depression on cognition in Parkinson's disease: a pattern of impairment distinguishable from Alzheimer's disease. Neurology 45: 672-676.
39. Troster AI, Stalp LD, Paolo AM, et al. 1995b. Neuropsychological impairment in Parkinson's disease with and without depression. Arch Neurol 52: 1164-1169.
40. Weintraub D, Moberg PJ, Duda JE, et al. 2004. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease. J Am Geriatr Soc 52: 784-788.